Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
March 19, 2017 10:04 PM 2 min read

How Much You'd Spend On Healthcare Under New GOP Plan, By Income

by Jayson Derrick
Follow
The Affordable Care Act, aka
Obamacare, is on its way out and will be replaced with a House GOP bill called the American Health Care Act, which has been dubbed "Trumpcare," "Ryancare" and even "Obamacare Lite." While the final details have yet to be confirmed,
Statista
is speculating that the new plan will reduce the federal budget deficit by $337 billion over the next decade — but at the expense of millions of Americans.

Statista, citing data from the non-partisan Congressional Budget Office, stated that 24 million people could lose health insurance coverage in nine years. In addition, overall premiums would fall by around 10 percent in 2026 compared to the current law, this statistic varies depending on age and income.

Who Benefits And Loses The Most?

A single person aged 21 and earning $26,500 per year is already paying $1,700 for insurance premiums under the current plan, but under the Republican bill, it could fall to $1,450. However, a 64-year-old person who is paying $1,700 for an insurance premium today (based on 6.4 percent of their annual income) would see this figure soar to $14,600 (55.1 percent of their income) under the Republican plan.

On the other hand, a 64-year-old on a $68,200 annual wage is paying $15,300 (22.4 percent of their annual earnings) and would benefit from the Republican plan, seeing the payment drop to $14,600.

The Numbers

Statista compiled the average projected share of annual income spent on insurance premiums in 2026 under both Obamacare and the Republican plan.

  • 21-year-old single with an annual income of $26,500: 6.4 percent under Obamacare, 5.5 percent under the Republican plan.
  • 40-year-old single person with an annual income of $26,500: 6.4 percent under Obamacare, 9.1 percent under the Republican plan.
  • 64-year-old single person with an annual income of $26,500: 6.4 percent under Obamacare, 55.1 percent under the Republican plan.
  • 21-year-old single with an annual income of $68,200: 7.5 percent under Obamacare, 2.1 percent under the Republican plan.
  • 40-year-old single with an annual income of $68,200: 9.5 percent under Obamacare, 3.5 percent under the Republican plan.
  • 64-year-old single with an annual income of $68,200: 22.4 percent under Obamacare, 21.4 percent under the Republican plan.

Related Links:

Stocks To Watch As CBO Expected To Release Score For GOP Healthcare Bill
Here's Who's Getting A Tax Cut Under The New Healthcare Proposal (You're Probably Not Included)
_______
Image Credit: By Office of the Speaker - https://twitter.com/SpeakerRyan, Public Domain, via Wikimedia Commons
Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
EducationHealth CarePoliticsTopicsMediaPersonal FinanceGeneralhealthcareobamacareStatista
IBB Logo
IBBiShares Biotechnology ETF
$172.640.08%
Overview
XLV Logo
XLVState Street Health Care Select Sector SPDR ETF
$157.940.17%
IBB Logo
IBBiShares Biotechnology ETF
$172.640.08%
Overview
XLV Logo
XLVState Street Health Care Select Sector SPDR ETF
$157.940.17%
Comments
Loading...